Born from IQVIA’s acquisition of Prioritis, this platform unites HTA Accelerator and PrismAccess to address market access challenges. It provides >50,000 HTA publications, >6,000 clinical trial records, >8,000 regulatory documents, pricing data for >6,000 products, and 900+ agreements. Users can access 100+ agency profiles with daily policy updates. The solution helps navigate restricted access, pricing pressures, and EU joint assessments. Features include powerful search, newsfeeds, visual dashboards, and integration with in-house systems, enabling informed lifecycle decisions and effective access strategies.

Join for free to read